Yuanzhong Pan

5PUBLICATIONS
15CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 30, 2025
The PAX3-FOXO1 fusion gene reduces cell-ECM interactions and TGFβ signaling in rhabdomyosarcoma.

Antonios Chronopoulos, Ivan Chavez, Chandra Kaladhar Vemula

|May 15, 2024
Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancer.

Yuanzhong Pan, Tsu-Pei Chiu, Lili Zhou

|Jan 06, 2023
A BMP-2-triggered in vivo osteo-organoid for cell therapy.

Kai Dai, Qinghao Zhang, Shunshu Deng

|Apr 13, 2021
Clocking cancer: the circadian clock as a target in cancer therapy.

Francesca Battaglin, Priscilla Chan, Yuanzhong Pan

Pageof 1